Merck (MRK) Tops Q3 EPS by 10c

Go back to Merck (MRK) Tops Q3 EPS by 10c

Merck (MRK) PT Raised to $120 at Cantor Fitzgerald

October 27, 2022 12:47 PM EDT

Cantor Fitzgerald analyst Louise Chen raised the price target on Merck (NYSE: MRK) to $120.00 (from $107.00) while maintaining an Overweight rating.

The analyst commented, ". Post a 3Q22 sales and EPS beat relative to FactSet consensus, we are reiterating our Overweight (OW) rating. We are... More